Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 7, 2026
- Accession no.
- 0001673232-26-000004
- Filed
- Jan 7, 2026
- Trade date
- Jan 5, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 1 derivative transaction. Open-market sales total $7.13M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | MOption exerciseAcquired | +14,625 | $117.76 | +$1,722,240 | 14,625 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −697 | $480.68 | −$335,033.96 | 13,928 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,657 | $481.86 | −$798,442.02 | 12,271 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −873 | $482.72 | −$421,414.56 | 11,398 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −697 | $483.80 | −$337,208.6 | 10,701 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,169 | $485.00 | −$566,965 | 9,532 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,669 | $486.05 | −$811,217.45 | 7,863 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −856 | $487.40 | −$417,214.4 | 7,007 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,189 | $488.38 | −$580,683.82 | 5,818 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −677 | $489.49 | −$331,384.73 | 5,141 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,659 | $490.11 | −$813,092.49 | 3,482 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,201 | $491.35 | −$590,111.35 | 2,281 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −1,110 | $492.44 | −$546,608.4 | 1,171 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −374 | $493.47 | −$184,557.78 | 797 | Indirect | |
| Jan 5, 2026 | Common Stock | SSaleDisposed | −797 | $494.27 | −$393,933.19 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Common Stock | MOption exerciseDisposed | −14,625 | $0.00 | $0 | 97,125 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.